The Value of Economic Modeling Studies in the Evaluation of Treatment Strategies for Multiple Sclerosis
Outcomes Research in the Health-Care System
The Economics of Gene Therapy and of Pharmacogenetics
Regulatory Issues for Health-Related Quality of Life—PhRMA Health Outcomes Committee Workshop, 1999
The Direct Cost and Incidence of Systemic Fungal Infections
The Incidence and Cost of Hospitalization for 5-FU Toxicity among Medicare Beneficiaries with Metastatic Colorectal Cancer
Cost-Effectiveness Analysis of Interferon Beta in Multiple Sclerosis
A Method for Identifying the Financial Burden of Hospitalized Infants on Families
Letter to the Editor